Search results
Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know
Zacks via Yahoo Finance· 2 hours agoVertex Pharmaceuticals (VRTX) closed the most recent trading day at $397.70, moving -0.76% from the...
(VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest By Benzinga
Investing.com· 5 hours agoVertex Pharmaceuticals's (NYSE:VRTX) short percent of float has fallen 3.75% since its last report....
Vertex selected to join Oracle ISV Accelerator for SaaS Initiative
The Accountant via Yahoo Finance· 10 hours agoVertex, a global provider of tax technology solutions and a member of Oracle PartnerNetwork (OPN),...
Selling Buzz: Vertex Pharmaceuticals, Inc. [VRTX] SVP & Chief Accounting Officer Ambrose Kristen...
Knox Daily· 17 hours agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Vertex Pharmaceuticals, Inc. shares valued at $100,560 were ...
In a Transformative Year, Vertex Advances Its Commitment to Corporate Responsibility; Announces 2023...
3BL CSRwire· 11 hours ago2023 was a transformative year for Vertex. The company made significant advances toward delivering on its core mission of creating transformative medicines for people with ...
Sigma Planning Corp Sells 1,061 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
ETF DAILY NEWS· 17 hours agoSigma Planning Corp cut its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 37.3% during the 4th quarter, according to its most recent Form ...
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 3 days agoVertex Pharmaceuticals (NASDAQ: VRTX) has long been known for its expertise in treating cystic...
2 Fantastic Growth Stocks to Buy Right Now
Motley Fool via Yahoo Finance· 10 hours agoOn that note, here are two fantastic growth stocks to consider putting cash into the next time you go shopping for businesses to add to your basket of...
Vertex (NASDAQ:VERX) Price Target Cut to $32.00
ETF DAILY NEWS· 21 hours agoA number of other research firms have also issued reports on VERX. The Goldman Sachs Group raised their price target on shares of Vertex from $33.00 to $39.00 and gave the ...
Is Vertex Pharmaceuticals Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 7 days agoVertex Pharmaceuticals (NASDAQ: VRTX) is a growing pharmaceutical company with a robust cystic fibrosis (CF) business that generated nearly $10 billion...
